Lipid Metabolism, Inborn Errors
Information
- Disease name
- Lipid Metabolism, Inborn Errors
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05425745 | Active, not recruiting | Phase 3 | Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. | July 25, 2022 | September 30, 2024 |
| NCT00092807 | Completed | Phase 3 | Sitosterolemia Extension Study (0653-003)(COMPLETED) | February 12, 2001 | November 30, 2004 |
| NCT00092820 | Completed | Phase 3 | Sitosterolemia Extension Study (0653-004)(COMPLETED) | February 12, 2001 | November 30, 2004 |
| NCT00092898 | Completed | Phase 3 | An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) | October 2004 | October 2005 |
| NCT00477594 | Completed | Phase 2 | Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia | May 2007 | July 2011 |
| NCT00362180 | Completed | Phase 2 | Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration | July 2006 | September 2010 |
| NCT00004481 | Completed | Genetic Study of Sitosterolemia | November 1999 | ||
| NCT00607373 | Completed | Phase 3 | Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia | July 2007 | March 2009 |
| NCT00694109 | Completed | Phase 3 | An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia | April 2008 | September 2014 |
| NCT01782027 | Suspended | N/A | Mendelian Reverse Cholesterol Transport Study | October 2012 | July 31, 2024 |
| NCT00092833 | Terminated | Phase 3 | Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) | July 2002 | May 2005 |
| NCT00260299 | Terminated | Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency | February 2005 | January 31, 2016 | |
| NCT02635269 | Unknown status | N/A | Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy | January 2016 | December 2020 |
| NCT02707211 | Unknown status | Early Phase 1 | Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases | June 2016 | February 2017 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008052